Apixaban Prescription Suitability at Hospitals Saudi Arabia

Abstract

Studies conducted in Saudi Arabia have shown that most hospitalized NVAF patients were given the recommended dosage of apixaban and rivaroxaban. To increase the dosage appropriateness for hospitalized patients with nonvalvular atrial fibrillation (NVAF), healthcare providers should become knowledgeable about the latest recommendations for nonvitamin K-antagonist oral anticoagulants.
Aim of the study: The aim of this study was to examine Apixaban prescribing practices and identify instances of improper use.
Methodology: At Hospitals Saudi Arabia, descriptive statistics from a retrospective cross-sectional study were performed on 220 patients who were prescribed Apixaban.
Results: The findings verify that as the renal function test's normal rate rises or falls, the recommended dosage falls. This indicates that physicians are prescribing the right amount of apixaban.
Conclusion: The majority of apixaban prescriptions were written for patients based on approved dosages after pharmacist and physician verification.